These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1289038)

  • 21. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicological assessment of isomeric pesticides: a strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting.
    Battershill JM; Edwards PM; Johnson MK
    Food Chem Toxicol; 2004 Aug; 42(8):1279-85. PubMed ID: 15207378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of dichotomous response data from certain toxicological experiments.
    Haseman JK; Kupper LL
    Biometrics; 1979 Mar; 35(1):281-93. PubMed ID: 574026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, characterization and application of predictive-toxicology models.
    Rosenkranz HS; Cunningham AR; Zhang YP; Claycamp HG; Macina OT; Sussman NB; Grant SG; Klopman G
    SAR QSAR Environ Res; 1999; 10(2-3):277-98. PubMed ID: 10491854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of animal studies in toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1991 Oct; 14(2):167-77. PubMed ID: 1792351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic constitution and response to toxic chemicals--an overview.
    Womack JE
    J Toxicol Environ Health; 1979 Jan; 5(1):49-51. PubMed ID: 423304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility.
    Knight A
    ALTEX; 2007; 24(4):320-5. PubMed ID: 18288428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility.
    Knight A
    Altern Lab Anim; 2007 Dec; 35(6):641-59. PubMed ID: 18186670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement and estimation of electrophilic reactivity for predictive toxicology.
    Schwöbel JA; Koleva YK; Enoch SJ; Bajot F; Hewitt M; Madden JC; Roberts DW; Schultz TW; Cronin MT
    Chem Rev; 2011 Apr; 111(4):2562-96. PubMed ID: 21401043
    [No Abstract]   [Full Text] [Related]  

  • 35. The rat as a model for human toxicological evaluation.
    Oser BL
    J Toxicol Environ Health; 1981 Oct; 8(4):521-42. PubMed ID: 7338928
    [No Abstract]   [Full Text] [Related]  

  • 36. [Method for determining cumulation factor in toxicological studies].
    Triték VS; Guliaev AE
    Eksp Klin Farmakol; 2011; 74(3):35-6. PubMed ID: 21598636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal-to-human extrapolation using compartmental models.
    Medina RL; Albanese RA
    Neurosci Biobehav Rev; 1991; 15(1):57-61. PubMed ID: 2052199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluation of the C120 Magnum and Bionic traps to humanely kill mink.
    Proulx G; Pawlina IM; Wong RK
    J Wildl Dis; 1993 Jan; 29(1):184. PubMed ID: 8445786
    [No Abstract]   [Full Text] [Related]  

  • 39. [Development and application of adverse outcome pathway in toxicology research].
    Wang Y; Duan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1115-8. PubMed ID: 26887310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From comparative physiology to toxicological risk assessment.
    Koeman JH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(1-2):7-10. PubMed ID: 1677876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.